NPPB and COVID-19: Increases in NT-pro-BNP is a well-known clinical biomarker for heart disease and has also been shown to be affiliated with microvascular disease in the brain, kidney and heart [46] and cardiac complications and mortality rates in COVID-19 patients [47, 48].